Search

everythinglearnresearchcommunity

for

Search:↓

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Physical activity, height, and smoking affect prostate cancer risk.

Counterfeit drugs for bodybuilders often contain incorrect or contaminated ingredients and look like real products.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

The skin is vital for protection, temperature control, fluid balance, immunity, and sensing, with damage affecting daily life and mental health.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The normal human prostate does not significantly affect blood DHT levels.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Obesity is linked to more severe lower urinary tract symptoms.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Vertex pattern hair loss linked to higher prostate cancer risk.

Certain natural compounds called terpenes may help prevent prostate cancer.

Vitamin D may help regulate cholesterol and influence prostate cancer development.

Thermobalancing Therapy can treat enlarged prostate and improve men's quality of life.

Certain genetic markers may increase or decrease prostate cancer risk.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.